U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Wed Apr 02 21:17:24 GMT 2025
Edited
by admin
on Wed Apr 02 21:17:24 GMT 2025
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG4|KAPPA
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
6NM5PD4YTH
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Cenvacibart
INN  
Official Name English
REGN-7508
Preferred Name English
cenvacibart [INN]
Common Name English
immunoglobulin G4-kappa, anti-[Homo sapiens F11 (coagulation factor 11, coagulation factor XI, FXI, plasma thromboplastin antecedent, PTA)], Homo sapiens monoclonal antibody
Common Name English
Immunoglobulin G4 [226-proline], anti-(human blood-coagulation factor XI/XIa) (human monoclonal REGN7508 ?4-chain), disulfide with human monoclonal REGN7508 ?-chain, dimer
Common Name English
H-gamma4 heavy chain Homo sapiens (1-445) [VH (Homo sapiens IGHV3-11*01 (91.7%) -(IGHD) -IGHJ3*02 (100%), CDR-IMGT [8.8.11] (26-33.51-58.97-107)) (1-118) -Homo sapiens IGHG4*01, nG4m(a) CH2 L92, 12-G4v5 h P10(CH1 (119-216), hinge 1-12 S10>P (226) (217-22
Common Name English
Code System Code Type Description
CAS
3008610-21-4
Created by admin on Wed Apr 02 21:17:24 GMT 2025 , Edited by admin on Wed Apr 02 21:17:24 GMT 2025
PRIMARY
INN
13411
Created by admin on Wed Apr 02 21:17:24 GMT 2025 , Edited by admin on Wed Apr 02 21:17:24 GMT 2025
PRIMARY
FDA UNII
6NM5PD4YTH
Created by admin on Wed Apr 02 21:17:24 GMT 2025 , Edited by admin on Wed Apr 02 21:17:24 GMT 2025
PRIMARY
From To
1_22 1_96
2_22 2_96
2_132 4_214
2_145 2_201
2_259 2_319
1_132 3_214
2_365 2_423
3_23 3_88
3_134 3_194
4_23 4_88
4_134 4_194
1_145 1_201
1_224 2_224
1_227 2_227
1_259 1_319
1_365 1_423
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_295
N 2_295
Related Record Type Details
TARGET -> INHIBITOR
TARGET -> INHIBITOR
Related Record Type Details
ACTIVE MOIETY

Structural Modifications

Modification Type Location Site Location Type Residue Modified Extent Fragment Name Fragment Approval
AMINO_ACID_SUBSTITUTION [1_1] [2_1] N-TERMINUS Q PIDOLIC ACID SZB83O1W42
AMINO ACID REMOVAL [1_445] [2_445] C-TERMINUS K Amount: LYSINE K3Z4F929H6
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
Molecular Formula CHEMICAL